Risk Factors for Atherosclerosis in the Elderly

  • Wilbert S. Aronow
  • William H. Frishman

Abstract

Coronary artery disease (CAD) is the leading cause of death in elderly persons. CAD, peripheral arterial disease (PAD), atherothrombotic brain infarction (ABI), and extracranial carotid arterial disease (ECAD) are more common in old individuals than in middle-aged ones. CAD is the leading cause of death in old persons with PAD, ABI, or ECAD. This chapter discusses risk factors for CAD, PAD, ABI, and ECAD in old persons.

Keywords

Left Ventricular Hypertrophy Peripheral Arterial Disease Coronary Event Serum Total Cholesterol Systolic Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jajich CL, Ostfield AM, Freeman DH Jr. Smoking and coronary heart disease mortality in the elderly. JAMA 1984;252:2831–2834.PubMedCrossRefGoogle Scholar
  2. 2.
    Siegel D, Kuller L, Lazarus NB, et al. Predictors of cardiovascular events and mortality in the systolic hypertension in the elderly program pilot project. Am J Epidemiol 1987; 126:385–399.PubMedGoogle Scholar
  3. 3.
    Kannel WB, Vokonas PS. Primary risk factors for coronary heart disease in the elderly: the Framingham study. In: Wenger NK, Furberg CD, Pitt B (eds) Coronary Heart Disease in the Elderly. New York: Elsevier, 1986:60–92.Google Scholar
  4. 4.
    Benfante R, Reed D, Frank J. Does cigarette smoking have an independent effect on coronary heart disease incidence in the elderly? Am J Public Health 1991;81:897–899.PubMedCrossRefGoogle Scholar
  5. 5.
    LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991;324:1619–1625.PubMedCrossRefGoogle Scholar
  6. 6.
    Aronow WS, Ahn C. Risk factors for coronary events in a large cohort of very elderly patients with and without coronary artery disease. Am J Cardiol 1996;77:864–866.PubMedCrossRefGoogle Scholar
  7. 7.
    Aronow WS, Sales FF, Etienne F, et al. Prevalence of peripheral arterial disease and its correlation with risk factors for peripheral arterial disease in elderly patients in a long-term health care facility. Am J Cardiol 1988;62:644–646.PubMedCrossRefGoogle Scholar
  8. 8.
    Aronow WS, Ahn C, Gutstein H. Risk factors for new atherothrombotic brain infarction in 664 older men and 1488 older women. Am J Cardiol 1996;77:1380–1383.Google Scholar
  9. 9.
    Aronow WS, Ahn C, Kronzon I, et al. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy Am J Cardiol 1991;67:295–299.PubMedCrossRefGoogle Scholar
  10. 10.
    Hermanson B, Omenn GS, Kronmal RA, et al. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: results from the CASS registry. N Engl J Med 1988;319:1365–1369.PubMedCrossRefGoogle Scholar
  11. 11.
    Frishman WH, Sokol S, Aronson M, Wassertheil-Smoller S, Katzman R. Risk factors for cardiovascular and cerebrovascular diseases and dementia in the elderly: findings from the Bronx Longitudinal Aging Study. Curr Probi Cardiol 1998;23:1–68.CrossRefGoogle Scholar
  12. 12.
    Stokes J III, Kannel WB, Wolf PA, et al. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham study. Circulation 1987;75(suppl V):V65-V73.PubMedGoogle Scholar
  13. 13.
    Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham study. J Am Geriatr Soc 1985;33:13–18.PubMedGoogle Scholar
  14. 14.
    Pomrehn P, Duncan B, Weissfeld L, et al. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease: the Lipid Research Clinics Program Prevalence Study Circulation 1986;73(suppl I): 100–107.Google Scholar
  15. 15.
    Juergens JL, Barker NW, Hines EA Jr. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 1960;21:188–195.PubMedCrossRefGoogle Scholar
  16. 16.
    Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J 1978;1:1379–1381.PubMedCrossRefGoogle Scholar
  17. 17.
    Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60 year old men and women. J Chronic Dis 1981;34:261–269.PubMedCrossRefGoogle Scholar
  18. 18.
    Beach KW, Brunzell JD, Strandness DE Jr. Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus: relation to smoking and form of therapy. Arteriosclerosis 1982;2:275–280.PubMedCrossRefGoogle Scholar
  19. 19.
    Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982;211:249–256.PubMedCrossRefGoogle Scholar
  20. 20.
    Aronow WS, Ahn C, Mercando AD, et al. Prognostic significance of silent ischemia in elderly patients with peripheral arterial disease with and without previous myocardial infarction. Am J Cardiol 1992;69:137–139.PubMedCrossRefGoogle Scholar
  21. 21.
    Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br Med J 1989;298:789–794.CrossRefGoogle Scholar
  22. 22.
    Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J Clin Res 1985;291:97–104.CrossRefGoogle Scholar
  23. 23.
    Wolf PA, D’Agostino PS, Kannel WB, et al. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA 1988;259:1025–1029.PubMedCrossRefGoogle Scholar
  24. 24.
    Rodgers RL, Meyer JS, Judd BW, et al. Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers. JAMA 1985;253:2970–2974.CrossRefGoogle Scholar
  25. 25.
    Candelise L, Bianchi F, Galligoni F, et al. Italian multicenter study on reversible cerebral ischemic attacks. III. Influence of age and risk factors on cerebrovascular atherosclerosis. Stroke 1984;15:379–382.PubMedCrossRefGoogle Scholar
  26. 26.
    Ford CS, Crouse JR III, Howard G, et al. The role of plasma lipids in carotid bifurcation atherosclerosis. Ann Neurol 1985;17:301–303.PubMedCrossRefGoogle Scholar
  27. 27.
    Crouse JR III, Toole JF, McKinney WM. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987;18: 990–996.PubMedCrossRefGoogle Scholar
  28. 28.
    Tell GS, Howard G, McKinney WM, et al. Cigarette smoking cessation and extracranial carotid atherosclerosis. JAMA 1989;261:1178–1180.PubMedCrossRefGoogle Scholar
  29. 29.
    Bots ML, Breslau BJ, Briet E, et al. Cardiovascular determinants of carotid artery disease: the Rotterdam Elderly Study. Hypertension 1992;19:717–720.PubMedCrossRefGoogle Scholar
  30. 30.
    Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 1992;23:1705–1711.PubMedCrossRefGoogle Scholar
  31. 31.
    Aronow WS, Ahn C, Schoenfeld MR. Risk factors for extracranial internal or common carotid arterial disease in elderly patients. Am J Cardiol 1993;71:1479–1481.PubMedCrossRefGoogle Scholar
  32. 32.
    Tell GS, Polak JF, Ward BJ, et al. Relation of smoking with carotid artery wall thickness and stenosis in older adults: the Cardiovascular Health Study. Circulation 1994;90: 2905–2908.PubMedCrossRefGoogle Scholar
  33. 33.
    Aronow WS, Kronzon I. Prevalence of coronary risk factors in elderly blacks and whites. J Am Geriatr Soc 1991;39:567–570.PubMedGoogle Scholar
  34. 34.
    Applegate WB, Rutan GH. Advances in management of hypertension in older persons. J Am Geriatr Soc 1992;40: 1164–1174.PubMedGoogle Scholar
  35. 35.
    Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on Hypertension in Elderly Trial. Lancet 1985;1:1349–1354.PubMedCrossRefGoogle Scholar
  36. 36.
    Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP Hypertension). Lancet 1991;338:1281–1285.PubMedCrossRefGoogle Scholar
  37. 37.
    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255–3264.CrossRefGoogle Scholar
  38. 38.
    MRC Working Party. Medical Research Council Trial on treatment of hypertension in older adults: principal results. Br Med J 1992;304:405–412.CrossRefGoogle Scholar
  39. 39.
    Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413–2444.CrossRefGoogle Scholar
  40. 40.
    Aronow WS, Ahn C, Mercando AD, et al. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients >62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction >40%. Am J Cardiol 1994;74:267–270.PubMedCrossRefGoogle Scholar
  41. 41.
    Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993;71:602–604.PubMedCrossRefGoogle Scholar
  42. 42.
    Garland C, Barrett-Connor E, Suarez L, et al. Isolated systolic hypertension and mortality after age 60 years: a prospective population-based study. Am J Epidemiol 1983;118:365–376.PubMedGoogle Scholar
  43. 43.
    Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986;293:1145–1151.CrossRefGoogle Scholar
  44. 44.
    Wolf PA. Cerebrovascular disease in the elderly. In: Tresch DD, Aronow WS (eds) Cardiovascular Disease in the Elderly Patient. New York: Marcel Dekker, 1999:125–147.Google Scholar
  45. 45.
    Shekelle RB, Ostfeld AM, Klawans HL. Hypertension and risk of stroke in an elderly population. Stroke 1974;5:71–75.PubMedCrossRefGoogle Scholar
  46. 46.
    Lavie CJ, Ventura HO, Messerli FH. Left ventricular hypertrophy in the elderly. Cardiol Elderly 1994;2:362–369.Google Scholar
  47. 47.
    Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13(suppl I):2–2.CrossRefGoogle Scholar
  48. 48.
    Applegate WB, Miller ST, Elam JT, et al. Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. Arch Intern Med 1992; 152:1162–1166.PubMedCrossRefGoogle Scholar
  49. 49.
    Ruben S, Espeland MA, Ryu J, et al. Individual variation in susceptibility to extracranial carotid atherosclerosis. Arteriosclerosis 1988;8:389–397.CrossRefGoogle Scholar
  50. 50.
    Aronow WS, Kronzon I, Schoenfeld MR. Left ventricular hypertrophy is more prevalent in patients with systemic hypertension with extracranial carotid arterial disease than in patients with systemic hypertension without extracranial carotid arterial disease. Am J Cardiol 1995;76: 192–193.PubMedCrossRefGoogle Scholar
  51. 51.
    Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 1987;60:851–931.CrossRefGoogle Scholar
  52. 52.
    Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiographic and electrocardiographic left ventricular hypertrophy in predicting new cardiac events and atherothrombotic brain infarction in elderly patients with systemic hypertension or coronary artery disease. Am J Noninvas Cardiol 1989;3:367–370.Google Scholar
  53. 53.
    Kahn S, Frishman WH, Weissman S, et al. Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10 year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1996;44:524–529.PubMedGoogle Scholar
  54. 54.
    Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989;110:101–107.PubMedCrossRefGoogle Scholar
  55. 55.
    Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age. Am J Cardiol 1988;61:1130–1132.PubMedCrossRefGoogle Scholar
  56. 56.
    Aronow WS, Epstein S, Koenigsberg M, et al. Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia, and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol 1988;62: 1124–1125.PubMedCrossRefGoogle Scholar
  57. 57.
    Aronow WS, Gutstein H, Hsieh FY. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol 1989;63:366–367.PubMedCrossRefGoogle Scholar
  58. 58.
    Aronow WS, Ahn C, Kronzon I, et al. Association of plasma renin activity and echocardiographic left ventricular hypertrophy with frequency of new coronary events and new atherothrombotic brain infarction in older persons with systemic hypertension. Am J Cardiol 1997;79:1543–1545.PubMedCrossRefGoogle Scholar
  59. 59.
    Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA 1994;272:33–36.PubMedCrossRefGoogle Scholar
  60. 60.
    Aronow WS, Ahn C, Kronzon I, et al. Association of extracranial carotid arterial disease, prior atherothrombotic brain infarction, systemic hypertension, and left ventricular hypertrophy with the incidence of new atherothrombotic brain infarction at 45 month follow-up of 1482 older patients. Am J Cardiol 1997;79:991–993.PubMedCrossRefGoogle Scholar
  61. 61.
    Aronow WS. Left ventricular hypertrophy. J Am Geriatr Soc 1992;40:71–80.PubMedGoogle Scholar
  62. 62.
    Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992;5: 95–110.PubMedGoogle Scholar
  63. 63.
    Kannel WB, D’Agostino RB, Levy D, et al. Prognostic significance of regression of left ventricular hypertrophy [abstract]. Circulation 1988;78(suppl II):89.Google Scholar
  64. 64.
    Koren MJ, Savage DD, Casale PN, et al. Changes in left ventricular mass predict risk in essential hypertension [abstract]. Circulation 1990;82(suppl III):29.Google Scholar
  65. 65.
    Castelli SP, Wilson PWF, Levy D, et al. Cardiovascular risk factors in the elderly. Am J Cardiol 1989;63:12H-19H.PubMedCrossRefGoogle Scholar
  66. 66.
    Wong ND, Wilson PWF, Kannel WB. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham study. Ann Intern Med 1991;115:687–693.PubMedCrossRefGoogle Scholar
  67. 67.
    Benfante R, Reed D. Is elevated serum cholesterol level a factor for coronary heart disease in the elderly? JAMA 1990;263:393–396.PubMedCrossRefGoogle Scholar
  68. 68.
    Barrett-Connor E, Suarez L, Khaw K-T, et al. Ischemic heart disease risk factors after age 50. J Chronic Dis 1984;37:903–908.PubMedCrossRefGoogle Scholar
  69. 69.
    Rubin SM, Sidney S, Black DM, et al. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 1990;113:916–920.PubMedCrossRefGoogle Scholar
  70. 70.
    Zimetbaum P, Frishman WH, Ooi WL, et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly: the Bronx Aging Study. Arterioscler Thromb 1992;12:416–423.PubMedCrossRefGoogle Scholar
  71. 71.
    Corti M-C, Guralnik JM, Salive ME, et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995;274:539–544.PubMedCrossRefGoogle Scholar
  72. 72.
    Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–1389.Google Scholar
  73. 73.
    Sacks FM, Pfefer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001–1009.PubMedCrossRefGoogle Scholar
  74. 74.
    Aronow WS, Ahn C. Correlation of serum lipids with the presence or absence of coronary artery disease in 1793 men and women aged =62 years. Am J Cardiol 1994;73:702–703.PubMedCrossRefGoogle Scholar
  75. 75.
    Lavie CJ, Milani RV. National Cholesterol Education Program’s recommendations and implications of “missing” high-density lipoprotein cholesterol in cardiac rehabilitation programs. Am J Cardiol 1991;68:1087–1088.PubMedCrossRefGoogle Scholar
  76. 76.
    Fowkes FGR, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331–340.PubMedGoogle Scholar
  77. 77.
    Beach KW, Brunzell JD, Conquest JD, et al. The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and non-insulin-dependent diabetes. Diabetes 1979;28:836–840.PubMedGoogle Scholar
  78. 78.
    Criqui MH, Browner D, Fronek A, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989;129:1110–1119.PubMedGoogle Scholar
  79. 79.
    Aronow WS, Ahn C. Correlation of serum lipids with the presence or absence of atherothrombotic brain infarction and peripheral arterial disease in 1834 men and women aged =62 years. Am J Cardiol 1994;73:995–997.PubMedCrossRefGoogle Scholar
  80. 80.
    Iso H, Jacobs DR Jr, Wentworth D, et al. Serum cholesterol levels and six year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention trial. N Engl J Med 1989;320:904–910.PubMedCrossRefGoogle Scholar
  81. 81.
    Bihari-Varga M, Szekely J, Gruber E. Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease: the influence of various risk factors. Atherosclerosis 1981;40:337–345.PubMedCrossRefGoogle Scholar
  82. 82.
    Crouse JR III, Byington RP, Hoen HM, et al. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997;157:1305–1310.PubMedCrossRefGoogle Scholar
  83. 83.
    O’Leary DH, Anderson KM, Wolf PA, et al. Cholesterol and carotid atherosclerosis in older persons: the Framingham study. Ann Epidemiol 1992;2:147–153.PubMedCrossRefGoogle Scholar
  84. 84.
    Salonen R, Seppanen K, Raurmaa R, et al. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988;8:788–792.PubMedCrossRefGoogle Scholar
  85. 85.
    Blankenhorn DH, Selzer RH, Crawford DW, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery: two and four year reduction of intima-media thickness measured by ultrasound. Circulation 1993;88:20–28.PubMedCrossRefGoogle Scholar
  86. 86.
    Furberg CD, Adams HP, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679–1687.PubMedCrossRefGoogle Scholar
  87. 87.
    Crouse JR III, Byington RP, Bond MG, et al. Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 1995;75:455-i59.PubMedCrossRefGoogle Scholar
  88. 88.
    Vokonas PS, Kannel WB. Epidemiology of coronary heart disease in the elderly. In: Tresch DD, Aronow WS (eds) Cardiovascular Disease in the Elderly Patient. New York: Marcel Dekker, 1999:139–164.Google Scholar
  89. 89.
    Barrett-Connor E, Khaw K-T Diabetes mellitus: an independent risk factor for stroke. Am J Epidemiol 1988;128: 116–123.PubMedGoogle Scholar
  90. 90.
    Bogousslavsky J, Regli F, Van Melle G. Risk factors and concomtants of internal carotid arterial occlusion or stenosis: a controlled study of 159 cases. Arch Neurol 1985; 42:864–867.PubMedCrossRefGoogle Scholar
  91. 91.
    Kannel WB, Cupples LA, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease. J Clin Epidemiol 1991;44:183–190.PubMedCrossRefGoogle Scholar
  92. 92.
    Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5 year risk of death in older women. JAMA 1993;269:483–487.PubMedCrossRefGoogle Scholar
  93. 93.
    Paffenbarger RS Jr, Hyde RT, Wing AL, et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986;314:605–613.PubMedCrossRefGoogle Scholar
  94. 94.
    Wenger NK. Physical inactivity as a risk factor for coronary heart disease in the elderly. Cardiol Elderly 1994;2: 375–379.Google Scholar
  95. 95.
    Paffenbarger RS Jr, Wing AL. Characteristics in youth predisposing to fatal stroke in later years. Lancet 1967;1:753–754.PubMedCrossRefGoogle Scholar
  96. 96.
    Paffenbarger RS Jr. Factors predisposing to fatal stroke in longshoremen. Prevent Med 1972;1:522–527.CrossRefGoogle Scholar
  97. 97.
    Williams MA, Maresh CM, Aronow WS, et al. The value of early outpatient cardiac exercise programs for the elderly in comparison with other selected age groups. Eur Heart J 1984;5(suppl E):113–115.PubMedCrossRefGoogle Scholar
  98. 98.
    Gillum RF. Stroke in blacks. Stroke 1988;19:1–9.PubMedCrossRefGoogle Scholar
  99. 99.
    Aronow WS. Prevalence of atherothrombotic brain infarction, coronary artery disease and peripheral arterial disease in elderly blacks, Hispanics and whites. Am J Cardiol 1992;70:1212–1213.PubMedCrossRefGoogle Scholar
  100. 100.
    Aronow WS, Ahn C, Schoenfeld M, et al. Extracranial carotid arterial disease: a prognostic factor for ather thrombotic brain infarction and cerebral transient ischemic attack. NY State J Med 1992;92:424–425.Google Scholar
  101. 101.
    Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984;199:223–233.PubMedCrossRefGoogle Scholar
  102. 102.
    Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors and mortality: the Whitehall study. Circulation 1990;82:1925–1931.PubMedCrossRefGoogle Scholar
  103. 103.
    Hertzer NR, Young JR, Beven EG, et al. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med 1985;145:849–852.PubMedCrossRefGoogle Scholar
  104. 104.
    Chimowitz MI, Mancini GBJ. Asymptomatic coronary artery disease in patients with stroke: prevalence, prognosis, diagnosis and treatment. Stroke 1992;23:433–436.PubMedCrossRefGoogle Scholar
  105. 105.
    Aronow WS, Ahn C, Schoenfeld MR, et al. Prognostic significance of silent myocardial ischemia in patients >61 years of age with extracranial internal or common carotid arterial disease with and without previous myocardial infarction. Am J Cardiol 1993;71:115–117.PubMedCrossRefGoogle Scholar
  106. 106.
    Aronow WS, Schoenfeld MR. Forty-five month follow-up of extracranial carotid arterial disease for new coronary events in elderly patients. Coron Artery Dis 1992;3:249–251.CrossRefGoogle Scholar
  107. 107.
    Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women >62 years of age. Am J Cardiol 1994;74:64–65.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Wilbert S. Aronow
  • William H. Frishman

There are no affiliations available

Personalised recommendations